XORTX Therapeutics XRTX
NASDAQ XRTX
$0.95 -0.04 (-4.30%)
As of: Oct 21, 2026 · 2:59 PM EDT

XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026)

Updated

XORTX Therapeutics' Operating Expenses was $178,654 in the quarter ended Jun 30, 2026, down 27.4% from $246,246 a year earlier but up 93.2% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Operating Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, XORTX Therapeutics' Operating Expenses was $504,732 through Jun 30, 2026, down 35.2% year-over-year; for the year ended Dec 31, 2025, it was $584,005, up 58.4% from the prior year.

  • Operating Expenses shows a five-year compound annual growth rate of 22.3% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Operating Expenses was $368,690 in the year ended Dec 31, 2024 (-82.2%), $2.07 million in the year ended Dec 31, 2023 (-71.3%), $7.22 million in the year ended Dec 31, 2022 (+779.4%) and $821,274 in the year ended Dec 31, 2021 (+284.5%).
  • Quarterly Operating Expenses has moved between $79,769 (the quarter ended Dec 31, 2024) and $2.59 million (the quarter ended Mar 31, 2022) over five years.
  • Compared with a year earlier, Operating Expenses was higher in four of the last eight quarters, with growth averaging 9.6%.
  • The best year-over-year quarter for Operating Expenses over five years was the quarter ended Sep 30, 2022 (growth of 398.1%); the worst was the quarter ended Dec 31, 2023 (a decline of 88.6%).
  • Per Business Quant data, XRTX's Operating Expenses in the three quarters before the quarter ended Jun 30, 2026 was $92,463 (quarter ended Mar 31, 2026), $115,479 (quarter ended Dec 31, 2025) and $118,136 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn 10.56 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn 18.20 Bn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn 6.68 Bn
10 XORTX Therapeutics 898,160.24 -2.40 Mn - 211,809.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 211,809.00
Mar 31, 2026 139,937.00
Dec 31, 2025 147,124.00
Sep 30, 2025 140,728.00
Jun 30, 2025 289,980.00
Mar 31, 2025 358,470.00
Dec 31, 2024 104,614.00
Sep 30, 2024 147,329.00
Jun 30, 2024 215,994.00
Dec 31, 2023 189,017.29
Sep 30, 2023 526,384.48
Jun 30, 2023 599,718.25
Mar 31, 2023 884,541.49
Dec 31, 2022 1.49 Mn
Sep 30, 2022 1.24 Mn
Jun 30, 2022 1.27 Mn
Mar 31, 2022 2.61 Mn
Dec 31, 2021 456,734.69
Sep 30, 2021 268,027.35
Jun 30, 2021 39,435.00
API Access

XORTX Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY